PHF19 interacted with the components of β-catenin inhibitor in the intercellular substance, inhibiting the decomposition of β-catenin, and promoted the signal transduction of β-catenin/T cells, thereby increasing the level of downstream IL-6 and promoting the movement of liver cancer cells (Cai et al., 2018). This evidence concerns the gene PHF19 and liver cancer.